Papain Suppresses Atopic Skin Inflammation Through Anti-Inflammatory Activities Using In Vitro and In Vivo Models

Overview

Journal Antioxidants (Basel)

Date 2024 Aug 29

PMID 39199175

Authors

Hye-Min Kim

Yun-Mi Kang

Minho Lee

Hyo-Jin An

Affiliations

Soon will be listed here.

Abstract

Papain (PN) is a proteolytic enzyme derived from L. While the pharmacological effects of PN have not been extensively studied compared to its enzymatic activity, PN also holds potential benefits beyond protein digestion. This study aimed to investigate the potential effects of PN against skin inflammation in house dust mite body (Dfb)-exposed NC/Nga atopic dermatitis (AD) mice and human HaCaT keratinocytes and their underlying mechanisms. The effects of PN on the skin were assessed via histological examination, measurements of transepidermal water loss (TEWL), quantitative reverse transcription-polymerase chain reaction, Western blotting, and enzyme-linked immunosorbent assay. Our findings indicated that the oral intake of PN decreased the severity scores of lesions resembling AD, TEWL, and the levels of inflammatory cytokines and serum immunoglobulin E in Dfb-induced AD mice, along with a reduction in epidermal thickness and mast cell infiltration. Additionally, PN inhibited the activation of the mitogen-activated protein kinases (MAPKs) and the signal transducer and activator of transcription (STAT) pathways in Dfb-induced AD mice and HaCaT keratinocytes. Moreover, PN improved survival and reduced ROS production in HO-damaged HaCaT keratinocytes and enhanced the expression of antioxidant enzymes in Dfb-induced AD mice. Concludingly, the oral administration of PN suppressed inflammatory mediators and downregulated the MAPKs/STAT pathway, suggesting its potential role in AD pathogenesis.

References

Tan Q, Yang H, Liu E, Wang H . P38/ERK MAPK signaling pathways are involved in the regulation of filaggrin and involucrin by IL‑17. Mol Med Rep. 2017; 16(6):8863-8867. PMC: 5779966. DOI: 10.3892/mmr.2017.7689. View

da Silva C, Oliveira M, Motta E, de Almeida G, Varanda L, de Padula M . Genotoxic and Cytotoxic Safety Evaluation of Papain (Carica papaya L.) Using In Vitro Assays. J Biomed Biotechnol. 2010; 2010:197898. PMC: 2874931. DOI: 10.1155/2010/197898. View

Guggi D, Bernkop-Schnurch A . Improved paracellular uptake by the combination of different types of permeation enhancers. Int J Pharm. 2004; 288(1):141-50. DOI: 10.1016/j.ijpharm.2004.09.023. View

Dai X, Sayama K, Tohyama M, Shirakata Y, Yang L, Hirakawa S . The NF-kappaB, p38 MAPK and STAT1 pathways differentially regulate the dsRNA-mediated innate immune responses of epidermal keratinocytes. Int Immunol. 2008; 20(7):901-9. DOI: 10.1093/intimm/dxn048. View

Edamitsu T, Taguchi K, Okuyama R, Yamamoto M . AHR and NRF2 in Skin Homeostasis and Atopic Dermatitis. Antioxidants (Basel). 2022; 11(2). PMC: 8868544. DOI: 10.3390/antiox11020227. View

Danielsen E, Hansen G . Intestinal surfactant permeation enhancers and their interaction with enterocyte cell membranes in a mucosal explant system. Tissue Barriers. 2017; 5(3):e1361900. PMC: 5571779. DOI: 10.1080/21688370.2017.1361900. View

Agoro R, Piotet-Morin J, Palomo J, Michaudel C, Vigne S, Maillet I . IL-1R1-MyD88 axis elicits papain-induced lung inflammation. Eur J Immunol. 2016; 46(11):2531-2541. DOI: 10.1002/eji.201646366. View

Kanemaru K, Noguchi E, Tahara-Hanaoka S, Mizuno S, Tateno H, Denda-Nagai K . Clec10a regulates mite-induced dermatitis. Sci Immunol. 2019; 4(42). DOI: 10.1126/sciimmunol.aax6908. View

Schuler 4th C, Billi A, Maverakis E, Tsoi L, Gudjonsson J . Novel insights into atopic dermatitis. J Allergy Clin Immunol. 2022; 151(5):1145-1154. PMC: 10164702. DOI: 10.1016/j.jaci.2022.10.023. View

10.

Mayerle J, Sendler M, Hegyi E, Beyer G, Lerch M, Sahin-Toth M . Genetics, Cell Biology, and Pathophysiology of Pancreatitis. Gastroenterology. 2019; 156(7):1951-1968.e1. PMC: 6903413. DOI: 10.1053/j.gastro.2018.11.081. View

11.

Stremnitzer C, Manzano-Szalai K, Willensdorfer A, Starkl P, Pieper M, Konig P . Papain Degrades Tight Junction Proteins of Human Keratinocytes In Vitro and Sensitizes C57BL/6 Mice via the Skin Independent of its Enzymatic Activity or TLR4 Activation. J Invest Dermatol. 2015; 135(7):1790-1800. PMC: 4471117. DOI: 10.1038/jid.2015.58. View

12.

Howell M, Kuo F, Smith P . Targeting the Janus Kinase Family in Autoimmune Skin Diseases. Front Immunol. 2019; 10:2342. PMC: 6794457. DOI: 10.3389/fimmu.2019.02342. View

13.

Chopra R, Vakharia P, Sacotte R, Patel N, Immaneni S, White T . Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis. Br J Dermatol. 2017; 177(5):1316-1321. DOI: 10.1111/bjd.15641. View

14.

Kamijo S, Hara M, Suzuki M, Nakae S, Ogawa H, Okumura K . Innate IL-17A Enhances IL-33-Independent Skin Eosinophilia and IgE Response on Subcutaneous Papain Sensitization. J Invest Dermatol. 2020; 141(1):105-113.e14. DOI: 10.1016/j.jid.2020.05.088. View

15.

Kong Y, Jong Y, Balakrishnan M, Bok Z, Weng J, Tay K . Beneficial Role of Extracts and Phytochemicals on Oxidative Stress and Related Diseases: A Mini Review. Biology (Basel). 2021; 10(4). PMC: 8066973. DOI: 10.3390/biology10040287. View

16.

Klisic A, Bakic M, Karanikolic V . Comparative Analysis of Redox Homeostasis Biomarkers in Patients with Psoriasis and Atopic Dermatitis. Antioxidants (Basel). 2023; 12(10). PMC: 10604746. DOI: 10.3390/antiox12101875. View

17.

Kamijo S, Suzuki M, Hara M, Shimura S, Ochi H, Maruyama N . Subcutaneous Allergic Sensitization to Protease Allergen Is Dependent on Mast Cells but Not IL-33: Distinct Mechanisms between Subcutaneous and Intranasal Routes. J Immunol. 2016; 196(9):3559-69. DOI: 10.4049/jimmunol.1500717. View

18.

Kwon D, Bae Y, Ju S, Goh A, Youn G, Choi S . Casuarinin suppresses TARC/CCL17 and MDC/CCL22 production via blockade of NF-κB and STAT1 activation in HaCaT cells. Biochem Biophys Res Commun. 2012; 417(4):1254-9. DOI: 10.1016/j.bbrc.2011.12.119. View

19.

Ogawa T, Ishitsuka Y . The Role of KEAP1-NRF2 System in Atopic Dermatitis and Psoriasis. Antioxidants (Basel). 2022; 11(7). PMC: 9312147. DOI: 10.3390/antiox11071397. View

20.

Guttman-Yassky E, Bissonnette R, Ungar B, Suarez-Farinas M, Ardeleanu M, Esaki H . Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis. J Allergy Clin Immunol. 2018; 143(1):155-172. DOI: 10.1016/j.jaci.2018.08.022. View